Free Trial

Verve Therapeutics (VERV) SEC Filings & 10K Form

Verve Therapeutics logo
$5.25 -0.25 (-4.55%)
As of 01/14/2025 04:00 PM Eastern

Recent Verve Therapeutics SEC Filings

DateFilerForm TypeView
01/10/2025
8:24 PM
ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G/A
01/10/2025
8:00 AM
Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Lister Troy (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Politi Jason (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:30 PM
Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:23 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
11/05/2024
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
12:52 PM
VANGUARD GROUP INC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
10/16/2024
12:06 PM
STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
09/09/2024
3:36 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
08/08/2024
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
6:30 AM
Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:47 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
6:44 AM
Verve Therapeutics (Filer)
Form 8-K/A
06/28/2024
6:45 AM
MacLean Michael F (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
COATS LONNEL (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Morrison Jodie Pope (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Tatsis Ourania (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Cumbo Alexander (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
ADELMAN BURT A (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Mikhail Sheila (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Verve Therapeutics (Issuer)
Yeshwant Krishna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:30 AM
Morrison Jodie Pope (Reporting)
Verve Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/28/2024
6:30 AM
Tatsis Ourania (Reporting)
Verve Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/28/2024
6:30 AM
Politi Jason (Reporting)
Verve Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
3:42 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
06/25/2024
4:05 PM
Lister Troy (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
6:14 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:30 PM
Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
6:56 AM
Verve Therapeutics (Filer)
Form DEFA14A
04/26/2024
6:56 AM
Verve Therapeutics (Filer)
Form DEFA14A
04/26/2024
6:59 AM
Verve Therapeutics (Filer)
Form ARS
04/26/2024
6:59 AM
Verve Therapeutics (Filer)
Form ARS
04/26/2024
6:30 AM
Verve Therapeutics (Filer)
Form DEF 14A
04/03/2024
4:00 PM
Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
6:13 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
7:32 AM
Verve Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
7:00 AM
Verve Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2024
6:45 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
01/29/2024
3:00 PM
ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
01/23/2024
9:13 AM
STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
01/16/2024
10:45 AM
SINGER JAMES R (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VERV) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners